PHASE 3 STUDY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB VERSUS PLACEBO IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH TREATMENT‐NAÏVE FOLLICULAR LYMPHOMA (PERSPECTIVE). (June 2017) - Rule, S.; Flinn, I.W.; Fowler, N.; Chen, R.; Kwei, L.; Beaupre, D.M.; Chu, A.D.; Gordon, L.I.